Showing 1 - 6 results of 6 for search 'Dario Pasalic', query time: 0.03s
Refine Results
-
1
-
2
-
3
Food and Drug Administration approvals in phase 3 Cancer clinical trials by Joseph Abi Jaoude, Ramez Kouzy, Marc Ghabach, Roshal Patel, Dario Pasalic, Elie Ghossain, Austin B. Miller, Timothy A. Lin, Vivek Verma, C. David Fuller, Vivek Subbiah, Bruce D. Minsky, Ethan B. Ludmir, Cullen M. Taniguchi
Published 2021-06-01
Article -
4
Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials by Timothy A. Lin, Clifton David Fuller, Vivek Verma, Walker Mainwaring, Andres F. Espinoza, Austin B. Miller, Amit Jethanandani, Dario Pasalic, Prajnan Das, Bruce D. Minsky, Charles R. Thomas, David R. Fogelman, Vivek Subbiah, Ishwaria M. Subbiah, Ethan B. Ludmir
Published 2020-09-01
Article -
5
Proton Beam Therapy for Head and Neck Carcinoma of Unknown Primary: Toxicity and Quality of Life by Alexander D. Sherry, BS, Dario Pasalic, MD, G. Brandon Gunn, MD, C. David Fuller, MD, PhD, Jack Phan, MD, PhD, David I. Rosenthal, MD, William H. Morrison, MD, Erich M. Sturgis, MD, Neil D. Gross, MD, Maura L. Gillison, MD, PhD, Renata Ferrarotto, MD, Adel K. El-Naggar, MD, Adam S. Garden, MD, Frank MDSteven J.
Published 2021-06-01
Article -
6
Activity-Based Costing of Intensity-Modulated Proton versus Photon Therapy for Oropharyngeal Cancer by Nikhil G. Thaker, MD, David Boyce-Fappiano, MD, Matthew S. Ning, MD, Dario Pasalic, MD, Alexis Guzman, MBA, Grace Smith, MD, PhD, MPH, Emma B. Holliday, MD, James Incalcaterra, PhD, Adam S. Garden, MD, Simona F. Shaitelman, MD, G. Brandon Gunn, MD, C. David Fuller, MD, PhD, Pierre Blanchard, MD, Thomas W. Feeley, MD, Robert S. Kaplan, PhD, Steven J. Frank, MD
Published 2021-06-01
Article